Should fluoroquinolones be first-line antibiotics in the treatment of community-acquired pneumonia in areas with high incidence of tuberculosis?
Journal
Journal of Microbiology, Immunology and Infection
Journal Volume
40
Journal Issue
5
Pages
386-387
Date Issued
2007
Author(s)
SDGs
Other Subjects
ciprofloxacin; gemifloxacin; levofloxacin; moxifloxacin; ofloxacin; quinolone derivative; tuberculostatic agent; bacterium isolate; community acquired pneumonia; drug safety; editorial; endemic disease; human; incidence; multidrug resistance; Mycobacterium tuberculosis; outcome assessment; prevalence; primary health care; risk assessment; tuberculosis; Anti-Bacterial Agents; Community-Acquired Infections; Fluoroquinolones; Humans; Pneumonia; Taiwan; Tuberculosis
Type
editorial